Risk Factors for Post-Transplant Death in Donation after Circulatory Death Liver Transplantation

REFERENCES

• Adam R, Hoti E. Liver transplantation: the current situation. Semin Liver Dis. 2009;29(1):3–18.
   PubMed Web of Science ®Google Scholar
• Adam R, Karam V, Delvart V, et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol. 2012;57(3):675–688.
   PubMed Web of Science ®Google Scholar
• Chinese Society of Organ Transplantation CMA.National guidelines for donation after cardiac death in China. Hepato Pancreat Dis Int. 2013;12(3):234–238.
   PubMedGoogle Scholar
• Kootstra G, Daemen JH, Oomen AP. Categories of non-heart-beating donors. Transplant Proc. 1995;27(5):2893–2894.
   PubMed Web of Science ®Google Scholar
• Rosen CB, Heimbach JK, Gores GJ. Surgery for cholangio carcinoma: the role of liver transplantation. Hepato Pancreat Dis. 2008;10(3):186–189.
   Google Scholar
• European Association for the Study of the Liver. EASL clinical practice guidelines: liver transplantation. J Hepatol. 2016;64(2):433–485.
   PubMed Web of Science ®Google Scholar
• Zheng SS, Xu X, Wu J, et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 2008;85(12):1726–1732.
   PubMed Web of Science ®Google Scholar
• Lei JY, Wang WT, Yan LN. Hangzhou criteria for liver transplantation in hepatocellular carcinoma: a single-center experience. Eur J Gastroenterol Hepatol. 2014;26(2):200–204.
   PubMed Web of Science ®Google Scholar
• Audet M, Panaro F, Piardi T, et al. Are the Hangzhou criteria adaptable to hepatocellular carcinoma patients for liver transplantation in Western countries? Liver Transpl. 2009;15(7):822–823.
   PubMedGoogle Scholar
• Gonzalez FX, Garcia-Valdecasas JC, Grande L, et al. Vena cava vascular reconstruction during orthotopic liver transplantation: a comparative study. Liver Transpl Surg. 1998;4(2):133–140.
   PubMedGoogle Scholar
• Qiu Y, Zhu X, Wang W, et al. Nutrition support with glutamine dipeptide in patients undergoing liver transplantation. Transpl Proc. 2009;41(10):4232–4237.
   PubMed Web of Science ®Google Scholar
• Bratzler DW, Houck PM, Surgical Infection Prevention Guideline Writers. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg. 2005;189(4):395–404.
   PubMed Web of Science ®Google Scholar
• Weimann A, Braga M, Harsanyi L, et al. ESPEN guidelines on enteral nutrition: surgery, including organ transplantation. Clin Nutr. 2006;25(2):224–244.
   PubMed Web of Science ®Google Scholar
• Sanchez AJ, Aranda-Michel J. Nutrition for the liver transplant patient. Liver Transpl. 2006;12(9):1310–1316.
   PubMed Web of Science ®Google Scholar
• Khan SA, Davidson BR, Goldin RD, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut 2012;61(12):1657–1669.
   PubMed Web of Science ®Google Scholar
• Hayashi PH, Forman L, Steinberg T, et al. Model for end-stage liver disease score does not predict patient or graft survival in living donor liver transplant recipients. Liver Transpl. 2003;9(7):737–740.
   PubMed Web of Science ®Google Scholar
• Jacob M, Copley LP, Lewsey JD, et al. Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl. 2004;10(7):903–907.
   PubMed Web of Science ®Google Scholar
• Habib S, Berk B, Chang CC, et al. MELD and prediction of post-liver transplantation survival. Liver Transpl. 2006;12(3):440–447.
   PubMed Web of Science ®Google Scholar
• Rana A, Hardy MA, Halazun KJ, et al. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transpl. 2008;8(12):2537–2546.
   PubMed Web of Science ®Google Scholar
• Rana A, Jie T, Porubsky M, et al. The survival outcomes following liver transplantation (SOFT) score: validation with contemporaneous data and stratification of high-risk cohorts. Clin Transpl. 2013;27(4):627–632.
   Web of Science ®Google Scholar
• Zarrinpar A, Lee C, Noguchi E, et al. A rapid, reproducible, noninvasive predictor of liver graft survival. J Surg Res. 2015;197(1):183–190.
   PubMed Web of Science ®Google Scholar
• Olmedilla L, Perez-Pena JM, Ripoll C, et al. Early noninvasive measurement of the indocyanine green plasma disappearance rate accurately predicts early graft dysfunction and mortality after deceased donor liver transplantation. Liver Transpl. 2009;15(10):1247–1253.
   PubMed Web of Science ®Google Scholar
• Lock JF, Schwabauer E, Martus P, et al. Early diagnosis of primary nonfunction and indication for re-operation after liver transplantation. Liver Transpl. 2010;16(2):172–180.
   PubMed Web of Science ®Google Scholar
• Stockmann M, Lock JF, Malinowski M, et al. How to define initial poor graft function after liver transplantation? A new functional definition by the LiMAx test. Transpl Int. 2010;23(10):1023–1032.
   PubMed Web of Science ®Google Scholar
• Bolondi G, Mocchegiani F, Montalti R, et al. Predictive factors of short-term outcome after liver transplantation: a review. World JGastroenterol. 2016;22(26):5936–5949.
   PubMed Web of Science ®Google Scholar
• Baliga P, Merion RM, Turcotte JG, et al. Preoperative risk factor assessment in liver transplantation. Surgery 1992;112(4):704–710; discussion 10-1.
   PubMed Web of Science ®Google Scholar
• Christensen E. Prognostic models including the Child–Pugh, MELD and Mayo risk scores – where are we and where should we go? J Hepatol. 2004;41(2):344–350.
   PubMed Web of Science ®Google Scholar
• Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child–Pugh versus MELD. J Hepatol. 2005;42(Suppl 1):S100–S107.
   PubMed Web of Science ®Google Scholar
• Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. JHepatol. 1993;18(3):353–358.
   PubMed Web of Science ®Google Scholar
• Wasmuth HE, Kunz D, Yagmur E, et al. Patients with acute on chronic liver failure display “sepsis-like” immune paralysis. J Hepatol. 2005;42(2):195–201.
   PubMed Web of Science ®Google Scholar
• Christou L, Pappas G, Falagas ME. Bacterial infection-related morbidity and mortality in cirrhosis. Am JGastroenterol. 2007;102(7):1510–1517.
   PubMed Web of Science ®Google Scholar
• Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334(11):693–699.
   PubMed Web of Science ®Google Scholar
• Mazzaferro V, Bhoori S, Sposito C, et al. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl. 2011;17(Suppl 2):S44–S57.
   PubMed Web of Science ®Google Scholar
• Ravaioli M, Grazi GL, Piscaglia F, et al. Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. Am J Transplant. 2008;8(12):2547–2557.
   PubMed Web of Science ®Google Scholar
• Chapman WC, Majella Doyle MB, Stuart JE, et al. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation. Ann Surg. 2008;248(4):617–625.
   PubMed Web of Science ®Google Scholar
• Yao FY, Kerlan RK Jr, Hirose R, et al. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology 2008;48(3):819–827.
   PubMed Web of Science ®Google Scholar
• Grat M, Wronka KM, Stypulkowski J, et al. The Warsaw proposal for the use of extended selection criteria in liver transplantation for hepatocellular cancer. Ann Surg Oncol. 2017;24(2):526–534.
   PubMed Web of Science ®Google Scholar
• Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective exploratory analysis. Lancet Oncol. 2009;10(1):35–43.
   PubMed Web of Science ®Google Scholar
• Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33(6):1394–1403.
   PubMed Web of Science ®Google Scholar
• Zheng SS, Xu X, Wu J, et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 2008;85(12):1726–1732.
   PubMed Web of Science ®Google Scholar
• Foley DP, Fernandez LA, Leverson G, et al. Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg. 2005;242(5):724–731.
   PubMed Web of Science ®Google Scholar
• Foley DP, Fernandez LA, Leverson G, et al. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg. 2011;253(4):817–825.
   PubMed Web of Science ®Google Scholar
• de Vera ME, Lopez-Solis R, Dvorchik I, et al. Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant. 2009;9(4):773–781.
   PubMed Web of Science ®Google Scholar
• Mathur AK, Heimbach J, Steffick DE, et al. Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant. 2010;10(11):2512–2519.
   PubMed Web of Science ®Google Scholar